通过分子机制和免疫微环境分析,基于CRISPR/Cas9发现ccRCC的治疗机会
Bo Han1, Weiyang Liu1, Wanhui Wang1
1Department of Urology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Frontiers in immunology
|July 25, 2025
概括
这项研究确定了包括MELK在内的五个关键基因,以预测清细胞细胞癌 (ccRCC) 患者的结果. 开发的模型改善了风险分层,并指导了针对攻击性ccRCC的向治疗决策.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 清细胞细胞癌 (ccRCC) 是一种具有攻击性的癌症,由于转移性复发,其发病率不断上升,结果不佳.
- 现有的ccRCC的预后生物标志物缺乏可靠性,需要改进风险预测和治疗指导的方法.
研究的目的:
- 整合多学科数据,以发现ccRCC病原体中的关键基因.
- 开发一个强大的预后模型,以改善ccRCC患者的风险分层和治疗决策.
主要方法:
- 整合全基因组CRISPR查 (DepMap) 和转录基因概况 (TCGA) 以确定候选ccRCC基因.
- 利用LASSO和Cox回归来选择5个关键基因 (GGT6,HAO2,SLPI,MELK,EIF4A1) 用于预后模型的构建.
- 通过敲击实验研究了MELK的功能作用,并分析了瘤突变负担,免疫微环境和药物反应.
主要成果:
- 开发的预后模型有效地将ccRCC患者分为高风险和低风险组,具有不同的生存结果.
- 高风险的ccRCC病例表现出更高的突变负载,免疫抑制特征和激活的细胞因子通路,而低风险的病例显示出代谢通路活性.
- MELK knockdown抑制了癌细胞的增殖和迁移;高风险患者对针对性治疗如帕佐帕尼布和苏尼提尼布的反应有所改善.
结论:
- MELK在ccRCC的进展中发挥着关键作用,多组学模型阐明了其机制和与瘤微环境的相互作用.
- 这项研究为ccRCC风险分层和向治疗提供了新的策略,有可能识别新的治疗点.
- 在独立队列中进一步验证和对MELK监管网络的调查是合理的.
更多相关视频
10:21Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
Published on: January 5, 2018
13.3K
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.7K
相关概念视频
01:59CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
01:28CRISPR/Cas9 Genome Editing
252
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
252
02:53CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K